Table 3. Response to steroida treatment in patients with narrow-caliber and regular-caliber esophagus.
| Narrow-caliberb (n = 39) | Regular-caliber (n = 310) | P valuec | |
|---|---|---|---|
| Symptom response to steroids (n, %) | 14 (56) | 175 (85) | <0.01 |
| EGD response to steroids (n, %) | 17 (52) | 146 (76) | <0.01 |
| Histologic response to steroids (n, %) | 11 (33) | 119 (63) | <0.01 |
| Maximum eosinophil count before steroids (median, IQR) eos/hpf | 77.5 (33-100) | 60.0 (37-100) | 0.38 |
| Maximum eosinophils after steroids (median, IQR) eos/hpf | 45 (3-90) | 3 (0-34) | <0.01 |
a
Defined as any topical swallowed corticosteroid formulation.
b
Characterized by inability to pass an adult upper endoscope.
c
P values for significant difference in distribution of proportions and P value for difference in maximum eosinophil count.